{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:41:13Z","timestamp":1792341673523,"version":"4.4.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PNRR\\u2013 M4 C2 I1.1 -PRIN 2022CZTZ87- CUP F53D23006660006"],"award-info":[{"award-number":["PNRR\\u2013 M4 C2 I1.1 -PRIN 2022CZTZ87- CUP F53D23006660006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["2209 - GRT-2023A"],"award-info":[{"award-number":["2209 - GRT-2023A"]}],"id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neubiorev.2026.107005","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:11:16Z","timestamp":1790935876000},"page":"107005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges"],"prefix":"10.1016","volume":"191","author":[{"given":"Alessandro","family":"Rava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Di Trapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4165-1828","authenticated-orcid":false,"given":"Lawrence","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant Kumar","family":"Bid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-6045","authenticated-orcid":false,"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2026.107005_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051075","article-title":"PGC-1alpha Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response","volume":"12","author":"Abu Shelbayeh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.neubiorev.2026.107005_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101411","article-title":"A proteomic view of cellular and molecular effects of cannabis","volume":"11","author":"Abyadeh","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.neubiorev.2026.107005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118271","article-title":"Behavioural and molecular effects of cannabidiolic acid in mice","volume":"259","author":"Alegre-Zurano","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neubiorev.2026.107005_bib5","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.neubiorev.2026.107005_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/acschemneuro.0c00677","article-title":"Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome","volume":"12","author":"Anderson","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280842","article-title":"Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+\/- mouse model of Dravet syndrome","volume":"18","author":"Anderson","year":"2023","journal-title":"PLoS. One"},{"key":"10.1016\/j.neubiorev.2026.107005_bib8","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1111\/bph.15661","article-title":"Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy","volume":"178","author":"Anderson","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib9","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jnatprod.9b00600","article-title":"Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome","volume":"82","author":"Anderson","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.neubiorev.2026.107005_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42238-021-00113-w","article-title":"Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome","volume":"4","author":"Anderson","year":"2022","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acs.molpharmaceut.8b01344","article-title":"Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood-Brain Barrier Both in Vitro and in Vivo","volume":"16","author":"Aparicio-Blanco","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neubiorev.2026.107005_bib12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/np8002673","article-title":"Antibacterial cannabinoids from Cannabis sativa: a structure-activity study","volume":"71","author":"Appendino","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.neubiorev.2026.107005_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0000000000000565","article-title":"Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice","volume":"31","author":"Assareh","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103751","article-title":"Metabolomics and lipidomics strategies in modern drug discovery and development","volume":"28","author":"Astarita","year":"2023","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.neubiorev.2026.107005_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA(A) receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib16","article-title":"The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives","volume":"227","author":"Baldasso","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/can.2020.0073","article-title":"Evaluation of the Possible Anticonvulsant Effect of Delta(9)-Tetrahydrocannabinolic Acid in Murine Seizure Models","volume":"7","author":"Benson","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","article-title":"Epigenetic Regulation in Neurodegenerative Diseases","volume":"41","author":"Berson","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s11096-025-02078-9","article-title":"Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030","author":"Bindel","year":"2026","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.neubiorev.2026.107005_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a Potential Treatment for Anxiety Disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neubiorev.2026.107005_bib21","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bph.12043","article-title":"Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation","volume":"168","author":"Bolognini","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(89)90385-3","article-title":"Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels","volume":"166","author":"Bormann","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29091981","article-title":"CBD in the Treatment of Epilepsy","volume":"29","author":"Borowicz-Reutt","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.neubiorev.2026.107005_bib24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib25","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","article-title":"Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid","volume":"35","author":"Borrelli","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neubiorev.2026.107005_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-015-4100-1","article-title":"Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea","volume":"233","author":"Brierley","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2026.107005_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2026.107005_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109354","article-title":"The association between 5-HT1A binding and temporal lobe epilepsy: A meta-analysis of molecular imaging studies","volume":"145","author":"Cai","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neubiorev.2026.107005_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, Blood-Brain Barrier, and Brain Disposition","volume":"12","author":"Calapai","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neubiorev.2026.107005_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.euroneuro.2024.10.006","article-title":"Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review","volume":"91","author":"Camma","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib31","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1038\/s41467-025-60543-5","article-title":"Memantine inhibits calcium-permeable AMPA receptors","volume":"16","author":"Carrillo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2026.107005_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2990.2011.01248.x","article-title":"Delta(9)-tetrahydrocannabinol (Delta(9)-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease","volume":"38","author":"Carroll","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib33","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/mp.2014.127","article-title":"Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment","volume":"20","author":"Cheng","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.107005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2022.100035","article-title":"Whole proteome mapping of compound-protein interactions","volume":"2","author":"Chirasani","year":"2022","journal-title":"Curr. Res. Chem. Biol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpba.2017.11.044","article-title":"Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA)","volume":"149","author":"Citti","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.neubiorev.2026.107005_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","article-title":"dCas9-Based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in dravet syndrome mice","volume":"28","author":"Colasante","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neubiorev.2026.107005_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.neubiorev.2026.107005_bib41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbagen.2019.01.002","article-title":"Identification and characterization of phytocannabinoids as novel dual PPARalpha\/gamma agonists by a computational and in vitro experimental approach","volume":"1863","author":"D'Aniello","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.neubiorev.2026.107005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104915","article-title":"CBG, CBD, Delta9-THC, CBN, CBGA, CBDA and Delta9-THCA as antioxidant agents and their intervention abilities in antioxidant action","volume":"152","author":"Dawidowicz","year":"2021","journal-title":"Fitoterapia"},{"key":"10.1016\/j.neubiorev.2026.107005_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11481-009-9177-z","article-title":"Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels","volume":"5","author":"De Petrocellis","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib44","series-title":"Handbook of Cannabis and Related Pathologies","article-title":"Chapter 2 - The Biosynthesis of Cannabinoids","author":"Degenhardt","year":"2017"},{"key":"10.1016\/j.neubiorev.2026.107005_bib45","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.3390\/cimb44100347","article-title":"Effect of Cannabidiolic Acid, N-Trans-Caffeoyltyramine and Cannabisin B from Hemp Seeds on microRNA Expression in Human Neural Cells","volume":"44","author":"Di Palo","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tig.2019.12.002","article-title":"Omics in neurodegenerative disease: hope or hype?","volume":"36","author":"Diaz-Ortiz","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.neubiorev.2026.107005_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1071\/CH21006","article-title":"The chemistry of cannabis and cannabinoids","volume":"74","author":"Duggan","year":"2021","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.neubiorev.2026.107005_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-020-00277-y","article-title":"A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT(1A) Receptors","volume":"39","author":"Echeverry","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/schbul\/sbaa153","article-title":"Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis","volume":"47","author":"Etchecopar-Etchart","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2026.107005_bib50","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/NRR.NRR-D-24-01054","article-title":"Potential common pathogenesis of several neurodegenerative diseases","volume":"21","author":"Fan","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12888-025-06932-y","article-title":"Global burden of mental disorders in 204 countries and territories, 1990-2021: results from the global burden of disease study 2021","volume":"25","author":"Fan","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.107005_bib52","article-title":"Acidic cannabinoids suppress proinflammatory cytokine release by blocking store-operated calcium entry","volume":"3","author":"Faouzi","year":"2022","journal-title":"Funct. (Oxf. )"},{"key":"10.1016\/j.neubiorev.2026.107005_bib53","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1046\/j.1432-1327.2001.02030.x","article-title":"Biosynthesis of cannabinoids. Incorporation experiments with (13)C-labeled glucoses","volume":"268","author":"Fellermeier","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neubiorev.2026.107005_bib54","article-title":"Preprint","author":"Floyd","year":"2025","journal-title":"Interaction Stomach Acid Blood pH Liver Metabolism Acidic Cannabinoids Partial Decarboxylation Metabolic Transformation Physiological Implications"},{"key":"10.1016\/j.neubiorev.2026.107005_bib55","doi-asserted-by":"crossref","unstructured":"Formato, M., Crescente, G., Scognamiglio, M., Fiorentino, A., Pecoraro, M.T., Piccolella, S., Catauro, M., Pacifico, S., 2020. (-)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research. Molecules 25.","DOI":"10.3390\/molecules25112638"},{"key":"10.1016\/j.neubiorev.2026.107005_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.939966","article-title":"Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs","volume":"9","author":"Garcia","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118288","article-title":"Preclinical evaluation of cannabidiolic acid as a neuroprotective agent in TDP-43 transgenic mice, an experimental model of amyotrophic lateral sclerosis","volume":"189","author":"Garcia-Toscano","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neubiorev.2026.107005_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/NDT.S350939","article-title":"Role of Calcium Homeostasis in Alzheimer's Disease","volume":"18","author":"Ge","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neubiorev.2026.107005_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","article-title":"Rodent tests of depression and anxiety: Construct validity and translational relevance","volume":"24","author":"Gencturk","year":"2024","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102402","article-title":"Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy","volume":"51","author":"Gherzi","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.neubiorev.2026.107005_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104944","article-title":"Cannabidiolic Acid Rescues Deficits in Hippocampal Long-Term Potentiation in Models of Alzheimer's Disease: An Electrophysiological and Proteomic Analysis","volume":"26","author":"Gil","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WCO.0000000000000901","article-title":"Serotonergic therapy in epilepsy","volume":"34","author":"Gilliam","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106525","article-title":"Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures","volume":"169","author":"Goerl","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116049","article-title":"Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis","volume":"339","author":"Han","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/ejn.16242","article-title":"Single-cell transcriptomics analysis of cellular heterogeneity and immune mechanisms in neurodegenerative diseases","volume":"59","author":"He","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2018.05.027","article-title":"Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression","volume":"351","author":"Hen-Shoval","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2024.04.033","article-title":"Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression","volume":"175","author":"Hen-Shoval","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043828","article-title":"Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats","volume":"24","author":"Hen-Shoval","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib69","article-title":"Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response","volume":"8","author":"Ilan","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.neubiorev.2026.107005_bib70","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/483269a","article-title":"Drug research: a plan for mental illness","volume":"483","author":"Insel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.107005_bib71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib72","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1089\/can.2023.0083","article-title":"Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats","volume":"8","author":"Jenkins","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1alpha, mitochondrial dysfunction, and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.107005_bib74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jms.1167","article-title":"Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS\/MS","volume":"42","author":"Jung","year":"2007","journal-title":"J. Mass. Spectrom."},{"key":"10.1016\/j.neubiorev.2026.107005_bib75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41583-024-00806-0","article-title":"Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases","volume":"25","author":"Kampmann","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119113","article-title":"Cannabidiol\/cannabidiolic acid-rich hemp (Cannabis sativa L.) extract attenuates cognitive impairments and glial activations in rats exposed to chronic stress","volume":"338","author":"Kamsrijai","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib77","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2026.107005_bib78","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.neurobiolaging.2014.09.028","article-title":"Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression","volume":"36","author":"Kariharan","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2026.107005_bib79","article-title":"The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib80","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/dta.3110","article-title":"Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study","volume":"13","author":"Kramer","year":"2021","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.neubiorev.2026.107005_bib81","article-title":"The Effects of Cannabis sativa L. Extract on Oxidative Stress Markers In Vivo","volume":"11","author":"Kubiliene","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.neubiorev.2026.107005_bib82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","article-title":"Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome","volume":"35","author":"Lattanzi","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2026.107005_bib83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/dta.1459","article-title":"Meconium drug testing reveals maternal misuse of medicinal opioids among addicted mothers","volume":"5","author":"Launiainen","year":"2013","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.neubiorev.2026.107005_bib84","article-title":"Post traumatic stress disorder associated hypothalamic-pituitary-adrenal axis dysregulation and physical illness","volume":"41","author":"Lawrence","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.neubiorev.2026.107005_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26072940","article-title":"Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus-A Mini Review","volume":"26","author":"Lei","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib86","article-title":"Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications","volume":"11","author":"Liu","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.neubiorev.2026.107005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2023.124754","article-title":"Green method for recovery of cannabinoids from Cannabis sativa flowers: pH-controlled aqueous leaching","volume":"326","author":"Lu","year":"2023","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib88","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.chembiol.2020.10.010","article-title":"Using the Oxytosis\/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases","volume":"27","author":"Maher","year":"2020","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tips.2024.12.005","article-title":"Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders","volume":"46","author":"Manzoni","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/abp.2025.15251","article-title":"Molecular targets of cannabinoids and their derivatives in epilepsy - a review with focus on CBD","volume":"72","author":"Marciniak","year":"2025","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041863","article-title":"Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research","volume":"22","author":"Melas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib93","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.xphs.2022.09.012","article-title":"Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment - in vitro characterization and in vivo efficacy studies","volume":"111","author":"Mihailova","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib94","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1111\/bph.15842","article-title":"Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro","volume":"179","author":"Mirlohi","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib95","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.phymed.2012.04.002","article-title":"Effects of cannabinoids Delta(9)-tetrahydrocannabinol, Delta(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures","volume":"19","author":"Moldzio","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neubiorev.2026.107005_bib96","first-page":"103","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.neubiorev.2026.107005_bib97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111689","article-title":"Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer's Disease. Review of Reviews","volume":"9","author":"Moreta","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2026.107005_bib99","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.forsciint.2018.03.020","article-title":"Delta-9-tetrahydrocannabinolic acid A (THC-A) in urine of a 15-month-old child: A case report","volume":"286","author":"Morini","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neubiorev.2026.107005_bib100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2025.08.009","article-title":"Molecular pathways linking the serotonin transporters (SERT) to depressive disorder: from mechanisms to treatments","volume":"584","author":"Murthy","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2026.107005_bib101","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPARgamma agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40211-025-00564-0","article-title":"Multi-omics approaches to major psychiatric disorders","volume":"40","author":"Oraki Kohshour","year":"2026","journal-title":"Neuropsychiatr"},{"key":"10.1016\/j.neubiorev.2026.107005_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113693","article-title":"Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity","volume":"171","author":"Palomares","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib104","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3389\/fneur.2018.00759","article-title":"Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis","volume":"9","author":"Pamplona","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/0028-3908(93)90029-3","article-title":"Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan)","volume":"32","author":"Parsons","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2026.107005_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051230","article-title":"Quality Traits of \"Cannabidiol Oils\": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations","volume":"23","author":"Pavlovic","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.neubiorev.2026.107005_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.858945","article-title":"Fever-Associated Seizures or Epilepsy: An Overview of Old and Recent Literature Acquisitions","volume":"10","author":"Pavone","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.neubiorev.2026.107005_bib108","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00228-018-2516-3","article-title":"Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study","volume":"74","author":"Pellesi","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41386-025-02179-z","article-title":"Epigenetic regulation of brain development, plasticity, and response to early-life stress","volume":"51","author":"Pena","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2026.107005_bib110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib111","series-title":"Handbook of cannabis","author":"Pertwee","year":"2014"},{"key":"10.1016\/j.neubiorev.2026.107005_bib112","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bph.14073","article-title":"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT(1A) receptor-mediated suppression of nausea and anxiety in rats","volume":"175","author":"Pertwee","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib113","first-page":"283","article-title":"Marijuana correlates with use of other illicit drugs in a pain patient population","author":"Pesce","year":"2010","journal-title":"Pain. Physician 13"},{"key":"10.1016\/j.neubiorev.2026.107005_bib114","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(25)01293-0","article-title":"The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis","volume":"406","author":"Pillinger","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.107005_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1611461","article-title":"Uncovering the molecular targets of phytocannabinoids: mechanistic insights from inverse molecular docking fingerprint approaches","volume":"16","author":"Ravnik","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib116","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/ejn.16278","article-title":"Therapeutic-like activity of cannabidiolic acid methyl ester in the MK-801 mouse model of schizophrenia: Role for cannabinoid CB1 and serotonin-1A receptors","volume":"59","author":"Richardson","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib117","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00213-018-5034-1","article-title":"Effect of cannabidiolic acid and \u2206(9)-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain","volume":"235","author":"Rock","year":"2018","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.neubiorev.2026.107005_bib118","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/can.2021.0041","article-title":"Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting","volume":"6","author":"Rock","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib119","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and Delta(9)-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.neubiorev.2026.107005_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-57369-0_1","article-title":"Constituents of Cannabis sativa","volume":"1264","author":"Rock","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib121","article-title":"Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (\u2212) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives","volume":"14","author":"Rodr\u00edguez-Carreiro","year":"2025","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.neubiorev.2026.107005_bib122","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","article-title":"Cannabis and epilepsy: An ancient treatment returns to the fore","volume":"70","author":"Russo","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neubiorev.2026.107005_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.675128","article-title":"The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a (+\/-) Mouse Model of Dravet Syndrome","volume":"12","author":"Satpute Janve","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib125","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1007\/s12035-019-1637-8","article-title":"Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease","volume":"56","author":"Schubert","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700270","article-title":"Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains","volume":"18","author":"Seabra","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.neubiorev.2026.107005_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.05.008","article-title":"Men and women respond differently to antipsychotic drugs","volume":"163","author":"Seeman","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2026.107005_bib128","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16515.1","article-title":"Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects","volume":"8","author":"Sekar","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.neubiorev.2026.107005_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101328","article-title":"Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine","volume":"16","author":"Serrano","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neubiorev.2026.107005_bib130","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/S0140-6736(26)00198-4","article-title":"Alzheimer's disease","volume":"407","author":"Serrano-Pozo","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.107005_bib131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.physbeh.2018.12.019","article-title":"Effects of cannabidiol in males and females in two different rat models of depression","volume":"201","author":"Shbiro","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neubiorev.2026.107005_bib132","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mad.2016.04.008","article-title":"Characterization of age-dependent changes in the striatum: Response to the mitochondrial toxin 3-nitropropionic acid","volume":"161","author":"Shinomol","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neubiorev.2026.107005_bib133","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42238-026-00387-y","article-title":"Therapeutic potential of acidic cannabinoids: an update","volume":"8","author":"Singh","year":"2026","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102821","article-title":"Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research","volume":"252","author":"Singhaarachchi","year":"2025","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41398-025-03562-6","article-title":"Mapping human brain cell type origin and diseases through single-cell transcriptomics","volume":"15","author":"Soorajkumar","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.107005_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110647","article-title":"Entrapment of drugs in dental calculus - Detection validation based on test results from post-mortem investigations","volume":"319","author":"Sorensen","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neubiorev.2026.107005_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169212","article-title":"The Role of Bioenergetics in Neurodegeneration","volume":"23","author":"Strope","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib138","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.yebeh.2016.12.032","article-title":"The current status of artisanal cannabis for the treatment of epilepsy in the United States","volume":"70","author":"Sulak","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neubiorev.2026.107005_bib139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5114\/fn.2020.94002","article-title":"miR-143-3p inhibition promotes neuronal survival in an Alzheimer's disease cell model by targeting neuregulin-1","volume":"58","author":"Sun","year":"2020","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2026.107005_bib141","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.forsciint.2015.07.019","article-title":"Determination of the relative percentage distribution of THCA and Delta(9)-THC in herbal cannabis seized in Austria - Impact of different storage temperatures on stability","volume":"254","author":"Taschwer","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neubiorev.2026.107005_bib142","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jad.2021.02.004","article-title":"Depressive and anxiety disorders in concert-A synthesis of findings on comorbidity in the NESDA study","volume":"284","author":"Ter Meulen","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2026.107005_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094271","article-title":"From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine","volume":"26","author":"Toader","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.107005_bib144","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00213-022-06119-3","article-title":"Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses","volume":"239","author":"Umpierrez","year":"2022","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.neubiorev.2026.107005_bib145","article-title":"Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty","volume":"11","author":"Vasincu","year":"2022","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.neubiorev.2026.107005_bib146","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-030-61663-2_3","article-title":"Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions","volume":"1297","author":"Vazquez","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003524","article-title":"Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis","volume":"18","author":"Velayudhan","year":"2021","journal-title":"PLoS. Med."},{"key":"10.1016\/j.neubiorev.2026.107005_bib148","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ptr.8369","article-title":"Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE-1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies","volume":"39","author":"Vitale","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.neubiorev.2026.107005_bib149","article-title":"The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need","author":"Wang","year":"2024","journal-title":"Aging Dis. 16 2937-2952"},{"key":"10.1016\/j.neubiorev.2026.107005_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102667","article-title":"Oxidative stress and mitochondrial impairment: Key drivers in neurodegenerative disorders","volume":"104","author":"Wen","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neubiorev.2026.107005_bib151","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.107005_bib152","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2215-0366(26)00015-5","article-title":"The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis","volume":"13","author":"Wilson","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.107005_bib153","unstructured":"Xixis, K.L., Samanta, D., Smith, T., Keenaghan, M., 2026. Febrile Seizure, StatPearls, Treasure Island (FL)."},{"key":"10.1016\/j.neubiorev.2026.107005_bib154","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77175-y","article-title":"vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa","volume":"10","author":"Zagzoog","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.107005_bib155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bcpt.14089","article-title":"An overview of major depression disorder: The endocannabinoid system as a potential target for therapy","volume":"135","author":"Zarazua-Guzman","year":"2024","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2026.107005_bib156","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/bph.14997","article-title":"An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain","volume":"177","author":"Zhu","year":"2020","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342600463X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342600463X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:00:12Z","timestamp":1792339212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976342600463X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":156,"alternative-id":["S014976342600463X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.107005","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.107005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107005"}}